EP4355769A4 - Dimeric collagen hybridizing peptides and methods of use thereof - Google Patents
Dimeric collagen hybridizing peptides and methods of use thereofInfo
- Publication number
- EP4355769A4 EP4355769A4 EP22825737.4A EP22825737A EP4355769A4 EP 4355769 A4 EP4355769 A4 EP 4355769A4 EP 22825737 A EP22825737 A EP 22825737A EP 4355769 A4 EP4355769 A4 EP 4355769A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- collagen hybridizing
- hybridizing peptides
- dimeric collagen
- dimeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/348,694 US20220050116A1 (en) | 2020-06-15 | 2021-06-15 | Dimeric collagen hybridizing peptides and methods of use thereof |
| PCT/US2022/033594 WO2022266200A1 (en) | 2021-06-15 | 2022-06-15 | Dimeric collagen hybridizing peptides and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4355769A1 EP4355769A1 (en) | 2024-04-24 |
| EP4355769A4 true EP4355769A4 (en) | 2025-04-30 |
Family
ID=94925111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22825737.4A Pending EP4355769A4 (en) | 2021-06-15 | 2022-06-15 | Dimeric collagen hybridizing peptides and methods of use thereof |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20220050116A1 (en) |
| EP (1) | EP4355769A4 (en) |
| WO (1) | WO2022266200A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115925988B (en) * | 2022-09-14 | 2023-08-22 | 中山大学附属第五医院 | A denatured collagen targeting antimicrobial peptide and its preparation method and application |
| KR20250155043A (en) * | 2023-03-02 | 2025-10-29 | 3헬릭스, 인코포레이티드 | Anti-inflammatory bioactive collagen hybrid peptides and methods of using the same |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180000960A1 (en) * | 2015-01-30 | 2018-01-04 | University Of Utah Research Foundation | Dimeric collagen hybridizing peptides and methods of using |
| WO2019044894A1 (en) * | 2017-08-31 | 2019-03-07 | 学校法人早稲田大学 | Cyclic peptide having collagen binding activity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013078091A1 (en) * | 2011-11-22 | 2013-05-30 | The Johns Hopkins University | Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use |
-
2021
- 2021-06-15 US US17/348,694 patent/US20220050116A1/en active Pending
-
2022
- 2022-06-15 EP EP22825737.4A patent/EP4355769A4/en active Pending
- 2022-06-15 WO PCT/US2022/033594 patent/WO2022266200A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180000960A1 (en) * | 2015-01-30 | 2018-01-04 | University Of Utah Research Foundation | Dimeric collagen hybridizing peptides and methods of using |
| WO2019044894A1 (en) * | 2017-08-31 | 2019-03-07 | 学校法人早稲田大学 | Cyclic peptide having collagen binding activity |
Non-Patent Citations (3)
| Title |
|---|
| KESSLER JULIAN L ET AL: "Supporting Information: Enrichment of Collagen Fragments Using Dimeric Collagen Hybridizing Peptide for Urinary Collagenomics", JOURNAL OF PROTEOME RESEARCH, vol. 19, no. 8, 5 June 2020 (2020-06-05), pages S1 - S18, XP093259402 * |
| KESSLER JULIAN L. ET AL: "Enrichment of Collagen Fragments Using Dimeric Collagen Hybridizing Peptide for Urinary Collagenomics", JOURNAL OF PROTEOME RESEARCH, vol. 19, no. 8, 5 June 2020 (2020-06-05), pages 2926 - 2932, XP093259396, ISSN: 1535-3893, DOI: 10.1021/acs.jproteome.0c00055 * |
| See also references of WO2022266200A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220050116A1 (en) | 2022-02-17 |
| WO2022266200A1 (en) | 2022-12-22 |
| EP4355769A1 (en) | 2024-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4093296A4 (en) | Paraxanthine-based bioactive composition and method of use thereof | |
| EP4209494A4 (en) | Ring-modified proline short peptide compound and use thereof | |
| EP4355769A4 (en) | Dimeric collagen hybridizing peptides and methods of use thereof | |
| EP3250240A4 (en) | Dimeric collagen hybridizing peptides and methods of using | |
| EP4277923A4 (en) | Type i membrane proteins heterodimers and methods of use thereof | |
| EP3849528A4 (en) | Nanoparticle formulations and methods of use for alpha connexin c-terminal peptides | |
| SG11202112487QA (en) | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | |
| EP3906307A4 (en) | Peptide libraries and methods of use thereof | |
| CA3257282A1 (en) | Collagen compositions and methods of use thereof | |
| EP4125777A4 (en) | High-strength collagen compositions and methods of use | |
| EP4163288A4 (en) | Novel nucleolin-binding peptide and use thereof | |
| EP4025585A4 (en) | Modified peptides and associated methods of use | |
| CA3265673A1 (en) | Brain penetrating peptides and methods of use thereof | |
| EP4269428A4 (en) | Novel peptide and use thereof | |
| AU2021372544A9 (en) | Peptides and methods of use | |
| AU2021371342A9 (en) | Peptides and methods of use | |
| EP4236982A4 (en) | Peptides and methods of use | |
| EP4236983A4 (en) | Peptides and methods of use | |
| HK40110424A (en) | Collagen compositions and methods of use thereof | |
| HK40103466B (en) | Ring-modified proline short peptide compound and use thereof | |
| HK40103466A (en) | Ring-modified proline short peptide compound and use thereof | |
| HK40090206A (en) | B7h3-targeting proteins and methods of use thereof | |
| HK40092545A (en) | Brk peptides and methods of use | |
| HK40104900A (en) | Fibroblast activation protein inhibitors and use thereof | |
| HK40081485A (en) | Peptides and methods for the treatment of multiple sclerosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20240112 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20250401 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 19/10 20060101ALI20250326BHEP Ipc: A61K 47/65 20170101ALI20250326BHEP Ipc: B01D 15/38 20060101ALI20250326BHEP Ipc: A61K 47/64 20170101ALI20250326BHEP Ipc: G01N 33/68 20060101ALI20250326BHEP Ipc: C07K 14/78 20060101AFI20250326BHEP |